Zhende Medical Co., Ltd. (SHA:603301)
China · Delayed Price · Currency is CNY 22.83
+0.61 (2.75%)
Aug 11, 2025, 2:45 PM CST
Paramount Global Market Cap
Zhende Medical has a market cap or net worth of 5.92 billion as of August 11, 2025. Its market cap has increased by 2.25% in one year.
Market Cap
5.92B
Enterprise Value
6.06B
Revenue
4.29B
Ranking
n/a
PE Ratio
16.38
Stock Price
$22.83
Market Cap Chart
Since April 12, 2018, Zhende Medical's market cap has increased from 2.85B to 5.92B, an increase of 107.35%. That is a compound annual growth rate of 10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 5.92B | 1.05% |
| Dec 31, 2024 | 5.86B | -9.58% |
| Dec 29, 2023 | 6.48B | -35.61% |
| Dec 30, 2022 | 10.06B | -13.02% |
| Dec 31, 2021 | 11.56B | -14.28% |
| Dec 31, 2020 | 13.49B | 343.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 406.93B |
| Shenzhen Mindray Bio-Medical Electronics | 279.02B |
| WuXi AppTec | 264.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.83B |
| Aier Eye Hospital Group | 118.61B |
| Sichuan Biokin Pharmaceutical | 118.48B |
| Shanghai United Imaging Healthcare | 107.18B |
| Yunnan Baiyao Group Co.,Ltd | 99.72B |